Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Journal of Nephrology & Renal DiseasesISSN: 2576-3962
https://sporbahisleri.livejournal.com https://wakelet.com/@SporBahisleri67459 https://theomnibuzz.com/author/sporbahisleri/ https://lessons.drawspace.com/profile/322207/sporbahisleri/workflow https://writeupcafe.com/profile/sporbahisleri/ http://www.pearltrees.com/sporbahisleri https://pharmahub.org/members/26874/blog https://www.zupyak.com/u/Spor-Bahisleri/ https://www.metroflog.co/sporbahisleri https://www.fuzia.com/fz/spor-bahisleri https://tr.pinterest.com/sporbahislerim/ https://my.getjealous.com/sporbahisleri https://sporbahisleri.contently.com https://hubpages.com/@sporbahisleri https://www.tumblr.com/sporbahisleri https://hub.docker.com/u/sporbahislerim https://betsiteleri.blogfree.net https://betsiteleri.amebaownd.com https://sporbahisleri.pixnet.net/blog https://betsiteleri.seesaa.net https://betsiteleri.threadless.com https://betsiteleri.neocities.org https://bahissiteleri.localinfo.jp https://betsiteleri.shopinfo.jp https://teletype.in/@betsiteleri https://ubl.xml.org/users/sporbahisleri https://betsiteleri.educatorpages.com https://betsiteleri.onlc.fr https://sporbahisleri.gumroad.com
Sanjeev Gulati Author
Subjects of specialization
Affiliation
Pilot study
Harvard Business School .
Biography
Telemedicine is the delivery of health care and/or health infor- mation in nephrology using electronic systems. There is no previous experience in Telenephrology from developing countries with limited resources like India.
Publications
Annual Meeting Abstract Open Access
Glomerular diseases and Immunosuppression in COVID-19 Times
Author(s): Sanjeev Gulati
Patients with Nephrotic Syndrome and Glomerulonephritis like Systemic Lupus Erythematosus(SLE), ANCA associated Glomerulonephritis and patients with other glomerular diseases, who are on moderate to high doses of immunosuppression, are at an increased risk of sever COVID infection because of their immunosuppressed state. However there are no studies to quantify the increase in risk in relation to the amount of immunosuppressant medications or their duration of use. Hence there is a lot of uncertainty regarding the management of these patients amongst the nephrology fraternity. We acknowledge that presently there is no data on this aspect, and what is being suggested is based on scientific logic and extrapolation of evidence from other infections. A simple way to evaluate these patients ... view more»
Google Scholars / Researchers Sites
